Saba Capital buys 400 Gabelli Healthcare shares

Rhea-AI Filing Summary

Gabelli Healthcare & WellnessRx Trust (GRX) reported an insider filing showing that Saba Capital Management, L.P., a ten percent owner, purchased 400 shares of Common Stock on September 11, 2026 in an open-market or private transaction at $9.71 per share, bringing its indirect holdings to 2,156,033 shares.

Insider Trade Summary

Net Buyer: 400 shares

Net Buy 1 txn

Insider Saba Capital Management, L.P.

Role 10% Owner

Bought 400 shs ($4K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	400	$9.71	$4K

Holdings After Transaction: Common Stock — 2,156,033 shares (Indirect, -)

Key Figures

Shares purchased: 400 shares Purchase price per share: $9.71 per share Shares owned after transaction: 2,156,033 shares +2 more

5 metrics

Shares purchased 400 shares Common Stock bought on September 11, 2026

Purchase price per share $9.71 per share Open-market or private purchase of GRX Common Stock

Shares owned after transaction 2,156,033 shares Indirectly held by Saba Capital Management, L.P. after the purchase

Net shares bought 400 shares Net buy reported across all transactions in this Form 4

Transaction date September 11, 2026 Date of the GRX Common Stock purchase

Key Terms

ten percent owner, indirect ownership, open market or private transaction

3 terms

ten percent owner regulatory

"Saba Capital Management, L.P., a ten percent owner, purchased shares"

indirect ownership financial

"its indirect holdings total 2,156,033 shares of Common Stock"

open market or private transaction financial

"Purchase in open market or private transaction at $9.71 per share"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction in GRX did Saba Capital Management, L.P. report?

Saba Capital Management, L.P., a ten percent owner of Gabelli Healthcare & WellnessRx Trust (GRX), reported a purchase of 400 shares of Common Stock on September 11, 2026 in an open-market or private transaction.

At what price were the GRX shares purchased in this Form 4 filing?

The filing states that the 400 GRX Common Stock shares were purchased at a price of $9.71 per share, with the price identified as a per-share amount for this open-market or private transaction.

How many GRX shares does Saba Capital Management hold after this transaction?

After the September 11, 2026 transaction, Saba Capital Management, L.P. is reported to indirectly hold 2,156,033 shares of Gabelli Healthcare & WellnessRx Trust Common Stock.

Was the GRX insider purchase made under a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is unchecked, and no footnote indicates a trading plan, so the reported 400-share purchase was not affirmed as made under a Rule 10b5-1 plan.

Is the GRX ownership reported as direct or indirect for Saba Capital Management?

The Form 4 identifies Saba Capital Management, L.P.’s position as indirect ownership, with the ownership type coded as indirect for the 2,156,033 Common Stock shares following the reported purchase.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/14/2026 - 09:39 AM Accepted by SEC EDGAR 09/14/2026 - 09:39 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Saba Capital Management, L.P.

(Last) (First) (Middle)

405 LEXINGTON AVENUE

58TH FLOOR

(Street)

NEW YORK NEW YORK 10174

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Gabelli Healthcare & WellnessRx Trust [ GRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2026		P		400	A	$9.71	2,156,033	I	-

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Saba Capital Management, L.P. By: Zachary Gindes	09/14/2026
	Boaz Weinstein	09/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)